Novartis | NOVN - Trade Creditors

Stock Price
117.82
Daily Change
-1.68 -1.41%
Monthly
-6.83%
Yearly
18.08%
Q1 Forecast
118.31

Novartis reported $4.56B in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alcon AG USD 926M 31M Dec/2025
Almirall EUR 258.05M 58.66M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Autolus Therapeutics Ltd USD 10.97M 5.56M Sep/2025
Bayer EUR 7.08B 700M Dec/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Fresenius EUR 1.08B 65M Sep/2025
Fresenius Medical Care EUR 835.55M 109.7M Dec/2025
Galapagos EUR 104.65M 4.02M Dec/2025
Genmab DKK 6M 2M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
GRIFOLS EUR 841M 37.68M Dec/2025
Hikma Pharmaceutical USD 715M 104M Dec/2025
J&J USD 11.99B 2.37B Dec/2025
Lonza CHF 471M 3M Dec/2024
Merck EUR 2.11B 182M Dec/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Orion EUR 123.5M 35.9M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Philips EUR 1.93B 214M Dec/2025
Recordati EUR 315.05M 15.17M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
UCB EUR 3.29B 2.54B Jun/2025